Ultrasound as a cancer chemotherapy sensitizer: the gap between laboratory and bedside

Bibliography

• Wood AKW, Sehgal CM. A review of low-intensity ultrasound for cancer therapy. Ultrasound Med Biol 2015;41:905–28
   PubMed Web of Science ®Google Scholar
• Tang J, Guha C, Tomé W. Biological effects induced by non-thermal ultrasound and implications for cancer therapy: A review of the current literature. Technol Cancer Res Treat 2015;14:221–35
   PubMed Web of Science ®Google Scholar
• Yu T, Li S, Zhao J, et al. Ultrasound: A chemotherapy sensitizer. Technol Cancer Res Treat 2006;6:51–60
   Google Scholar
• Han T, Das DB. Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: A review. Eur J Pharm Biopharm 2015;89:312–28
   PubMed Web of Science ®Google Scholar
• Lakshmanan S, Gupta GK, Avci P, et al. Physical energy for drug delivery: Poration, concentration and activation. Adv Drug Deliv Rev 2014;71:98–114
   PubMed Web of Science ®Google Scholar
• Sirsi SR, Borden MA. State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev 2014;72:3–14
   PubMed Web of Science ®Google Scholar
• Blenke EO, Mastrobattista E, Schiffelers RM. Strategies for triggered drug release from tumor targeted liposomes. Expert Opin Drug Deliv 2013;10:1399–410
   PubMed Web of Science ®Google Scholar
• Mo S, Coussios CC, Seymour L, et al. Ultrasound-enhanced drug delivery for cancer. Expert Opin Drug Deliv 2012;9:1525–38
   PubMed Web of Science ®Google Scholar
• Evjen TJ, Hagtvet E, Moussatov A, et al. In vivo monitoring of liposomal release in tumours following ultrasound stimulation. Eur J Pharm Biopharm 2013;84:526–31
   PubMed Web of Science ®Google Scholar
• Huang D, Wang L, Dong Y, et al. A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles. Eur J Pharm Biopharm 2014;88:104–15
   PubMed Web of Science ®Google Scholar
• Burgess A, Hynynen K. Drug delivery across the blood-brain barrier using focused ultrasound. Expert Opin Drug Deliv 2014;11:711–21
   PubMed Web of Science ®Google Scholar
• May JP, Li SD. Hyperthermia-induced drug targeting. Expert Opin Drug Deliv 2013;10:511–27
   PubMed Web of Science ®Google Scholar
• Malietzis G, Monzon L, Hand J, et al. High-intensity focused ultrasound: Advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology. Br J Radiol 2013;86:20130044
   PubMed Web of Science ®Google Scholar
• Maloney E, Hwang JH. Emerging HIFU applications in cancer therapy. Int J Hyperthermia 2015;31:302–9
   PubMed Web of Science ®Google Scholar
• Maruvada S, Liu Y, Soneson JE, et al. Comparison between experimental and computational methods for the acoustic and thermal characterization of therapeutic ultrasound fields. J Acoust Soc Am 2015;137:1704–13
   PubMed Web of Science ®Google Scholar
• Yu Y, Shen G, Zhou Y, et al. Quantitative assessment of acoustic intensity in the focused ultrasound field using hydrophone and infrared imaging. Ultrasound Med Biol 2013;39:2021–33
   PubMed Web of Science ®Google Scholar
• Yu T, Zhang Y. Sonochemotherapy against cancers. In: Nowak FM, editor. Sonochemistry: theory, reactions, syntheses, and applications. Nova Science Publishers; New York: 2010. p. 189–200
   Google Scholar
• Luo J, Ren X, Yu T. Efficacy of extracorporeal ultrasound-guided high intensity focused ultrasound: An evaluation based on controlled trials in China. Int J Radiat Biol 2015;91:480–5
   PubMed Web of Science ®Google Scholar
• Yu T, Yang Y, Zhang J, et al. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound. Eur J Pharm Biopharm 2015;91:103–10
   PubMed Web of Science ®Google Scholar
• He H, Huang H, Yu T. Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay. Int J Radiat Biol 2014;90:897–902
   PubMed Web of Science ®Google Scholar
• Fruehauf JP. In vitro assay-assisted treatment selection for women with breast or ovarian cancer. Endocr Relat Cancer 2002;9:171–82
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu J, Zhao Y, et al. Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles. Expert Opin Drug Deliv 2015;12:263–81
   PubMed Web of Science ®Google Scholar
• Escoffre JM, Piron J, Novell A, et al. Doxorubicin delivery into tumor cells with ultrasound and microbubbles. Mol Pharm 2011;8:799–806
   PubMed Web of Science ®Google Scholar
• Köberle B, Tomicic MT, Usanova SU, et al. Cisplatin resistance: Preclinical findings and clinical implications. Biochim Biophys Acta 2010;1806:172–82
   PubMed Web of Science ®Google Scholar
• Xia CQ, Smith PG. Drug efflux transporters and multidrug resistance in acute leukemia: Therapeutic impact and novel approaches to mediation. Mol Pharmacol 2012;82:1008–21
   PubMed Web of Science ®Google Scholar
• Wu F, Shao ZY, Zhai BJ, et al. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein. Ultrasound Med Biol 2011;37:151–9
   PubMed Web of Science ®Google Scholar
• Papanastasopoulos P, Stebbing J. Molecular basis of 5-fluorouracil-related toxicity: Lessons from clinical practice. Anticancer Res 2014;34:1531–5
   PubMed Web of Science ®Google Scholar
• Yu T, Zhang Y, He H, et al. Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin. Mol Pharm 2011;8:1408–15
   PubMed Web of Science ®Google Scholar
• Kaminski GA. Computational studies of the effect of shock waves on the binding of model complexes. J Chem Theory Comput 2014;10:4972–81
   PubMed Web of Science ®Google Scholar
• Shaw A, Nunn J. The feasibility of an infrared system for real-time visualization and mapping of ultrasound fields. Phys Med Biol 2010;55:N321–7
   PubMed Web of Science ®Google Scholar
• Yin H, Qiao Y, Cao H, et al. Cavitation mapping by sonochemiluminescence with less bubble displacement induced by acoustic radiation force in a 1.2 MHz HIFU. Ultrason Sonochem 2014;21:559–65
   PubMed Web of Science ®Google Scholar
• Swanton C. Intratumor heterogeneity: Evolution through space and time. Cancer Res 2012;72:4875–82
   PubMed Web of Science ®Google Scholar
• He H, Yu T, Zhang Y. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers. Ultraschall Med 2012;33:275–82
   PubMed Web of Science ®Google Scholar
• Xia W, Ma X, Li X, et al. Reversal effect of low-intensity ultrasound on adriamycin- resistant Human hepatoma cells in vitro and in vivo. Int J Imaging Syst Technol 2014;24:23–8
   Web of Science ®Google Scholar
• Port M, Glaesener S, Ruf C, et al. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer 2011;10:52
   PubMed Web of Science ®Google Scholar
• Gréen H, Lotfi K, Zackrisson AL, et al. Spontaneous reversal of P-glycoprotein expression in multidrug resistant cell lines. Pharmacol Toxicol 2003;93:297–304
   PubMedGoogle Scholar
• Duesberg P, Li R, Sachs R, et al. Cancer drug resistance: The central role of the karyotype. Drug Resist Updat 2007;10:51–8
   PubMed Web of Science ®Google Scholar
• Silva AS, Kam Y, Khin ZP, et al. Evolutionary approaches to prolong progression-free survival in breast cancer. Cancer Res 2012;72:6362–70
   PubMed Web of Science ®Google Scholar
• Yu T, Hu K, Bai J, et al. Reversal of adriamycin resistance in ovarian carcinoma cell line by combination of verapamil and low-level ultrasound. Ultrason Sonochem 2003;10:37–40
   PubMed Web of Science ®Google Scholar
• Vigano L, Locatelli A, Grasselli G, et al. Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy. Invest New Drugs 2001;19:179–96
   PubMed Web of Science ®Google Scholar
• Ruggeri BA, Camp F, Miknyoczki S. Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem Pharmacol 2014;87:150–61
   PubMed Web of Science ®Google Scholar
• Kahn J, Tofilon PJ, Camphausen K. Preclinical models in radiation oncology. Radiat Oncol 2012;7:223
   PubMed Web of Science ®Google Scholar
• Morjani H, Madoulet C. Immunosuppressors as multidrug resistance reversal agents. Methods Mol Biol 2010;59:433–46
   Google Scholar
• Bisogno G, Cowie F, Boddy A, et al. High-dose cyclosporin with etoposide – toxicity and pharmacokinetic interaction in children with solid tumours. Br J Cancer 1998;77:2304–9
   PubMed Web of Science ®Google Scholar
• Keizer HG, Pinedo HM, Schuurhuis GJ, et al. Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther 1990;47:219–31
   PubMed Web of Science ®Google Scholar
• Tata DB, Biglowt J, Wu J, et al. Ultrasound enhanced hydroxyl radical production from two clinically employed anticancer drugs, adriamycin and mitomycin C. Ultrason Sonochem 1996;3:39–45
   Web of Science ®Google Scholar
• Fu S, Xu T, Gao Z, et al. Clinical observation of the high-intensity focused ultrasound with FOLFOX4 in the treatment of advanced liver cancer. Med Philos 2010;31:24–5
   Google Scholar
• Li J, Xu G, Gu M, et al. Management of liver metastasis of nasopharyngeal cancer with HIFU combined with chemotherapy. Guangdong Med J 2007;28:402–4
   Google Scholar
• Zhang W, Zhong Y, Peng B, et al. The recent curative efficacy of therapy of high intensity focused ultrasound combined with systemic chemotherapy treatment on liver metastasis of colorectal cancer. Chin Mod Doctor 2013;51(32):154–6
   Google Scholar
• Sun J, Jiang L, Pan S, et al. Clinical research of the low-power HIFU on chemosensitivity enhancement effect in patients with advanced pancreatic cancer. Mod Oncol 2013;21:1805–8
   Google Scholar
• Bian X, Wei C, Wang Z, et al. Thermotherapy of high intensity focused ultrasound combined with chemotherapy in treatment of advanced pancreatic cancer. Med J Chin People Armed Police Forces 2009;20:515–17
   Google Scholar
• Chen P, Song J, Chen S, et al. Treatment of advanced pancreatic cancer with gemcitabine and HIFU. Chin Foreign Med Treat 2008;22:55–6
   Google Scholar
• Mu Q, Wang R, Huang P, et al. High intensity focused ultrasound in combination with chemotherapy: A clinical study for advanced malignancy of digestive system. Chin J Gastroenterol 2006;11:423–6
   Google Scholar
• Wang R, Mu Q, Liu L, et al. A clinical study of thermotherapy of HIFU in combination with chemotherapy on treating advanced pancreatic cancer. Acta Univ Med Nanjing 2003;23:460–3
   Google Scholar
• Qi Y. Clinical observation of treatment of advanced pancreatic cancer HIFU combined with gemcitabine. Cancer Res Prev Treat 2013;40:193–4
   Google Scholar
• Zhang Y, Ji Y, Zhao H, et al. Clinical outcome assessment of high intensity focused ultrasound ablation for pancreatic cancer in elderly patients. Geriatr Health Care 2013;19(5):308–11
   Google Scholar
• Wang N, Zhao H, Zheng X, et al. Clinical study of high-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma. J Clin Hepatol 2011;27:1193–5
   Google Scholar
• Zeng Q, Lu L, Zhang X, et al. High intensity focused ultrasound therapy in combination with gemcitabine for advanced pancreatic carcinoma. Chin Hepatobiliary Surg 2006;12:748–50
   Google Scholar
• Zhou H, Chang L, Gu Y. Efficacy of treatment of pancreatic cancer with HIFU combined with chemotherapy. Jilin Med J 2014;35:1458–9
   Google Scholar
• Liu C, Mao X, Fan C, et al. Therapeutic efficacy of high intensity focused ultrasound combined with neoadjuvant chemotherapy in breast cancer. J Chin Med Univ 2011;40:241–2
   Google Scholar
• Mu Q, Shu Y, Huang P, et al. High intensity focused ultrasound in combination with chemotherapy by the regime of PFC: A clinical study for advanced gastric carcinoma. J Nanjing Med Univ 2005;19:203–5
   Google Scholar
• Tian S, Li Z, Li X. Efficacy of treatment of advanced gastric cancer with HIFU combined PFC chemotherapy. Mod Digest Intervent 2014;19(3):170–2
   Google Scholar
• Hong L, Guo Z, Yu H, et al. Efficacy and safety of low-dose high intensity focused ultrasound combined with S-1 and oxaliplatin in metastatic colorectal patients with pelvic masses. Natl Med J China 2014;94:1929–32
   Google Scholar
• Xu H, Wang Q, Tao M, et al. Efficacy of treatment of advanced gastro-intestinal cancer with high intensity focused ultrasound combined with chemotherapy. Jiangsu Med J 2005;31:474–5
   Google Scholar